World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
12934
World Ranking
3009
National Ranking
1196

Vincent H. Tam publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Vincent H. Tam sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 195 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Vincent H. Tam D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Vincent H. Tam sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 61 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Vincent H. Tam is affiliated with the University of Houston in the United States and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. The main subfields reflected in their work include Pharmacology, Molecular Medicine, Infectious Diseases, Epidemiology, and Clinical Biochemistry.

Their research primarily focuses on topics related to Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antibiotic Use and Resistance, Antimicrobial Resistance in Staphylococcus, Pneumonia and Respiratory Infections, and Drug Transport and Resistance Mechanisms.

Vincent H. Tam has authored multiple papers, including the following recent publications:

  • New β-Lactam-β-Lactamase Inhibitor Combinations, 2020, Clinical Microbiology Reviews
  • Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils, 2021, Biomaterials Science
  • Erratum for Yahav et al., "New β-Lactam-β-Lactamase Inhibitor Combinations", 2021, Clinical Microbiology Reviews
  • Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review, 2020, The Journal of Infectious Diseases
  • Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models, 2020, Clinical Pharmacokinetics

Frequent publication venues for their work include:

  • Open Forum Infectious Diseases
  • Journal of Global Antimicrobial Resistance
  • Antimicrobial Agents and Chemotherapy
  • Computers & Chemical Engineering
  • SSRN Electronic Journal

Frequent coauthors collaborating with Vincent H. Tam consist of:

  • Cole S Hudson
  • Brianna M. Eales
  • Michael Nikolaou
  • Paul R. Merlau
  • Nazanin Pouya

Best Publications

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

    Elizabeth B. Hirsch;Vincent H. Tam;Vincent H. Tam

  • Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes.

    Elizabeth B Hirsch;Vincent H Tam

  • New β-Lactam-β-Lactamase Inhibitor Combinations.

    Dafna Yahav;Dafna Yahav;Christian G. Giske;Alise Grāmatniece;Alise Grāmatniece;Henrietta Abodakpi

  • Framework for optimisation of the clinical use of colistin and polymyxin B : the Prato polymyxin consensus

    Roger Leigh Nation;Jian Li;Otto Cars;William Couet

  • Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

    Nelson Jumbe;Arnold Louie;Robert Leary;Weiguo Liu

  • Pharmacodynamics of cefepime in patients with Gram-negative infections

    Vincent H. Tam;Peggy S. McKinnon;Ronda L. Akins;Michael J. Rybak

  • Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

    Vincent H. Tam;Amy N. Schilling;Giao Vo;Samer Kabbara

  • Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

    Andrea L. H. Kwa;ChinSiew Loh;Jenny G. H. Low;Asok Kurup

  • Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity

    Nathan P. Wiederhold;Dimitrios P. Kontoyiannis;Dimitrios P. Kontoyiannis;Jingduan Chi;Randall A. Prince;Randall A. Prince

  • Polymyxin B: similarities to and differences from colistin (polymyxin E).

    Andrea L Kwa;Sofia K Kasiakou;Vincent H Tam;Matthew E Falagas

  • Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

    Vincent H. Tam;Vincent H. Tam;Cary A. Rogers;Kai Tai Chang;Jaye S. Weston

  • Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa

    Vincent H. Tam;Amy N. Schilling;Shadi Neshat;Keith Poole

  • Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.

    Vincent H. Tam;Vincent H. Tam;Kai-Tai Chang;Kamilia Abdelraouf;Cristina G. Brioso

  • Risk Factors for Nephrotoxicity associated with Continuous Vancomycin Infusion in Outpatient Parenteral Antibiotic Therapy

    P.R. Ingram;D.C. Lye;P.A. Tambyah;W.P. Goh

  • In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.

    Kady Phe;Yuman Lee;Patrick M. McDaneld;Nishant Prasad

  • Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.

    Matthew E. Falagas;Matthew E. Falagas;Ioannis A. Bliziotis;Vincent H. Tam

  • The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance

    Vincent H. Tam;Arnold Louie;Mark R. Deziel;Weiguo Liu

  • Modelling time-kill studies to discern the pharmacodynamics of meropenem.

    Vincent H. Tam;Amy N. Schilling;Michael Nikolaou

  • In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

    Elizabeth B. Hirsch;Kimberly R. Ledesma;Kai Tai Chang;Michael S. Schwartz

Frequent Co-Authors

Kevin W. Garey
Kevin W. Garey University of Houston
David C. Lye
David C. Lye Tan Tock Seng Hospital
Russell E. Lewis
Russell E. Lewis University of Padua
Matthew E. Falagas
Matthew E. Falagas Alfa Institute of Biomedical Sciences
Luan D. Truong
Luan D. Truong Cornell University
Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
Song Gao
Song Gao University of Wisconsin–Madison
Cesar A. Arias
Cesar A. Arias The University of Texas Health Science Center at Houston
Brian T. Tsuji
Brian T. Tsuji University at Buffalo, State University of New York
George L. Drusano
George L. Drusano University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career opportunities in healthcare, research, and biotechnology. For those interested in healthcare, becoming a child specialist salary reflects the rewarding nature of specialized roles working with pediatric populations. These positions often require additional certifications but benefit from a background in biological sciences.

Students with unique backgrounds may find options through the best associate degrees for felons, which include pathways that align with microbiology-related fields. This highlights the growing inclusivity of online education for diverse learners aiming to build careers in science and health sectors.

For those seeking advanced clinical roles, online functional medicine NP programs offer a unique blend of conventional and holistic approaches, often building upon foundational microbiology knowledge to manage complex health conditions effectively.

Another promising path involves certifications such as the certified professional coder certification, which plays a crucial role in healthcare administration and medical billing, complementing scientific expertise with critical industry skills.

Best Scientists Citing Vincent H. Tam

Trending Scientists

Recently Published Articles